EGFR and lung carcinoma: Figure 1 summarises current knowledge of molecular predictors for EGFR-TKI discussed above. The development of EGFR-TKIs and the discovery of EGFR gene mutations have provided a great opportunity for translation of cancer biology into clinics to realise individualised therapies for lung cancer.